Patient, family caregiver, and economic outcomes of an integrated screening and novel stepped collaborative care intervention in the oncology setting in the USA (CARES): a randomised, parallel, phase 3 trial

干预(咨询) 医学 随机对照试验 相(物质) 家庭医学 肿瘤科 护理部 内科学 化学 有机化学
作者
Jennifer L. Steel,Charles J. George,Lauren Terhorst,Jonathan G. Yabes,Vincent Reyes,Dan P. Zandberg,Marci L. Nilsen,Gauri J. Kiefer,Jonas T. Johnson,Christopher L. Marsh,Jason Bierenbaum,Nishant Tageja,Michal T. Krauze,Robert VanderWeele,Vivek Goel,Gopala Ramineni,Michael H. Antoni,Yoram Vodovotz,Jon Walker,Samer Tohme,Timothy R. Billiar,David A. Geller
出处
期刊:The Lancet [Elsevier]
卷期号:403 (10434): 1351-1361 被引量:2
标识
DOI:10.1016/s0140-6736(24)00015-1
摘要

Background The current standard of care of screening and referring patients for treatment for symptoms, such as depression, pain, and fatigue, is not effective. This trial aimed to test the efficacy of an integrated screening and novel stepped collaborative care intervention versus standard of care for patients with cancer and at least one of the following symptoms: depression, pain, or fatigue. Methods This randomised, parallel, phase 3 trial was conducted in 29 oncology outpatient clinics associated with the UPMC Hillman Cancer Center in the USA. Patients (aged ≥21 years) with any cancer type and clinical levels of depression, pain, or fatigue (or all of these) were eligible. Eligible family caregivers were aged 21 years or older and providing care to a patient diagnosed with cancer who consented for this study. Patients were randomly assigned (1:1) to stepped collaborative care or standard of care using a central, permuted block design (sizes of 2, 4, and 6) stratified by sex and prognostic status. The biostatistician, oncologists, and outcome assessors were masked to treatment assignment. Stepped collaborative care was once-weekly cognitive behavioural therapy for 50–60 min from a care coordinator via telemedicine (eg, telephone or videoconferencing). Pharmacotherapy for symptoms might be initiated or changed if recommended by the treatment team or preferred by the patient. Standard of care was screening and referral to a health-care provider for treatment of symptoms. The primary outcome was health-related quality of life in patients at 6 months. Maintenance of the treatment benefits was assessed at 12 months. Participants included in the primary analysis were per intention to treat, which included patients missing one or both follow-up assessments. This trial was registered with ClinicalTrials.gov (NCT02939755). Findings Between Dec 5, 2016, and April 8, 2021, 459 patients and 190 family caregivers were enrolled. 222 patients were assigned to standard of care and 237 to stepped collaborative care. Of 459 patients, 201 (44%) were male and 258 (56%) were female. Patients in the stepped collaborative care group had a greater 0–6-month improvement in health-related quality of life than patients in the standard-of-care group (p=0·013, effect size 0·09). Health-related quality of life was maintained for the stepped collaborative care group (p=0·74, effect size 0·01). Patients in the stepped collaborative care group had greater 0–6-month improvements than the standard-of-care group in emotional (p=0·012), functional (p=0·042), and physical (p=0·033) wellbeing. No adverse events were reported by patients in either group and deaths were considered unrelated to the study. Interpretation An integrated screening and novel stepped collaborative care intervention, compared with the current standard of care, is recommended to improve health-related quality of life. The findings of this study will advance the implementation of guideline concordant care (screening and treatment) and has the potential to shift the practice of screening and treatment paradigm nationwide, improving outcomes for patients diagnosed with cancer. Funding US National Cancer Institute.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
郑思榆关注了科研通微信公众号
3秒前
账户已注销应助boook采纳,获得30
5秒前
小二郎应助boook采纳,获得10
6秒前
Ava应助科研通管家采纳,获得10
6秒前
lyy应助科研通管家采纳,获得10
6秒前
桐桐应助科研通管家采纳,获得10
6秒前
6秒前
6秒前
7秒前
香蕉觅云应助516165165采纳,获得10
9秒前
小王同学完成签到,获得积分10
9秒前
zhouzhou发布了新的文献求助10
10秒前
10秒前
Joshua完成签到,获得积分10
10秒前
yuyuyu完成签到,获得积分10
12秒前
叛逆黑洞完成签到,获得积分10
12秒前
Orange应助maplesirup采纳,获得10
13秒前
英俊的雁易完成签到,获得积分10
13秒前
16秒前
16秒前
去看海嘛发布了新的文献求助10
16秒前
Mason完成签到,获得积分10
17秒前
19秒前
nenoaowu发布了新的文献求助10
19秒前
zhangz完成签到,获得积分10
21秒前
pai先生完成签到 ,获得积分10
24秒前
孤独如曼发布了新的文献求助10
24秒前
lysun完成签到,获得积分10
24秒前
QP发布了新的文献求助10
26秒前
无花果应助adkis采纳,获得10
26秒前
GHL完成签到,获得积分10
27秒前
Vita完成签到,获得积分10
28秒前
zhouzhou完成签到,获得积分10
29秒前
30秒前
Furmark_14完成签到,获得积分10
33秒前
毛豆爸爸应助125ljw采纳,获得10
34秒前
sunshine完成签到 ,获得积分10
35秒前
36秒前
37秒前
高分求助中
Sustainability in ’Tides Chemistry 1500
The ACS Guide to Scholarly Communication 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Handbook of the Mammals of the World – Volume 3: Primates 805
Ethnicities: Media, Health, and Coping 800
Historia de la ciencia jurídica europea 600
Gerard de Lairesse : an artist between stage and studio 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3069610
求助须知:如何正确求助?哪些是违规求助? 2723682
关于积分的说明 7482606
捐赠科研通 2370745
什么是DOI,文献DOI怎么找? 1257136
科研通“疑难数据库(出版商)”最低求助积分说明 609851
版权声明 596861